Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis

Molecular Cell

Volumn 26, Issue 5, 2007, Pages 745-752

  Chang, Tsung Cheng ^a   Wentzel, Erik A ^a   Kent, Oliver A ^a   Ramachandran, Kalyani ^a   Mullendore, Michael ^a   Lee, Kwang Hyuck ^a   Feldmann, Georg ^a   Yamakuchi, Munekazu ^a   Ferlito, Marcella ^a   Lowenstein, Charles J ^a   Arking, Dan E ^a   Beer, Michael A ^a   Maitra, Anirban ^a   Mendell, Joshua T ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CELLCYCLE; RNA

Indexed keywords

MICRORNA; MICRORNA 34A; PROTEIN P53; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER; CELL CYCLE PROGRESSION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENOTOXICITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PROMOTER REGION; TRANSACTIVATION;

APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; DNA DAMAGE; GENE EXPRESSION; HUMANS; MICRORNAS; PANCREATIC NEOPLASMS; PROMOTER REGIONS (GENETICS); RNA, NEOPLASM; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

EID: 34249817549     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2007.05.010     Document Type: Article

References (51)

1. Ambros V. The functions of animal microRNAs. Nature 431 (2004) 350-355
2. Bagchi A., Papazoglu C., Wu Y., Capurso D., Brodt M., Francis D., Bredel M., Vogel H., and Mills A.A. CHD5 is a tumor suppressor at human 1p36. Cell 128 (2007) 459-475
3. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
4. Bello M.J., Leone P.E., Vaquero J., de Campos J.M., Kusak M.E., Sarasa J.L., Pestana A., and Rey J.A. Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int. J. Cancer 64 (1995) 207-210
5. Bieche I., Champeme M.H., Matifas F., Cropp C.S., Callahan R., and Lidereau R. Two distinct regions involved in 1p deletion in human primary breast cancer. Cancer Res. 53 (1993) 1990-1994
6. Bolstad B.M., Irizarry R.A., Astrand M., and Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 (2003) 185-193
7. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J.P., Sedivy J.M., Kinzler K.W., and Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282 (1998) 1497-1501
8. Cai X., Hagedorn C.H., and Cullen B.R. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10 (2004) 1957-1966
9. Calhoun E.S., Hucl T., Gallmeier E., West K.M., Arking D.E., Maitra A., Iacobuzio-Donahue C.A., Chakravarti A., Hruban R.H., and Kern S.E. Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays. Cancer Res. 66 (2006) 7920-7928
10. Calin G.A., and Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6 (2006) 857-866
11. Dennis Jr. G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., and Lempicki R.A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4 (2003) 3
12. Esquela-Kerscher A., and Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 6 (2006) 259-269
13. Fridman J.S., and Lowe S.W. Control of apoptosis by p53. Oncogene 22 (2003) 9030-9040
14. Giono L.E., and Manfredi J.J. The p53 tumor suppressor participates in multiple cell cycle checkpoints. J. Cell. Physiol. 209 (2006) 13-20
15. Hammond S.M. MicroRNAs as oncogenes. Curr. Opin. Genet. Dev. 16 (2006) 4-9
16. He L., and Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5 (2004) 522-531
17. Hemann M.T., Fridman J.S., Zilfou J.T., Hernando E., Paddison P.J., Cordon-Cardo C., Hannon G.J., and Lowe S.W. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat. Genet. 33 (2003) 396-400
18. Hwang H.W., Wentzel E.A., and Mendell J.T. A hexanucleotide element directs microRNA nuclear import. Science 315 (2007) 97-100
19. Ihaka J., and Gentleman R. R: A language for data analysis and graphics. J. Comput. Graph. Statist. 5 (1996) 299-314
20. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., and Speed T.P. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 (2003) 249-264
21. Kendziorski C.M., Newton M.A., Lan H., and Gould M.N. On parametric empirical Bayes methods for comparing multiple groups using replicated gene expression profiles. Stat. Med. 22 (2003) 3899-3914
22. Kim V.N. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 6 (2005) 376-385
23. Kim Y.K., and Kim V.N. Processing of intronic microRNAs. EMBO J. 26 (2007) 775-783
24. Kirsch D.G., and Kastan M.B. Tumor-suppressor p53: implications for tumor development and prognosis. J. Clin. Oncol. 16 (1998) 3158-3168
25. Krutzfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., and Stoffel M. Silencing of microRNAs in vivo with 'antagomirs.'. Nature 438 (2005) 685-689
26. Lee K.M., Nguyen C., Ulrich A.B., Pour P.M., and Ouellette M.M. Immortalization with telomerase of the Nestin-positive cells of the human pancreas. Biochem. Biophys. Res. Commun. 301 (2003) 1038-1044
27. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Lee J., Provost P., Radmark O., Kim S., and Kim V.N. The nuclear RNase III Drosha initiates microRNA processing. Nature 425 (2003) 415-419
28. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., and Kim V.N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23 (2004) 4051-4060
29. Lim L.P., Lau N.C., Garrett-Engele P., Grimson A., Schelter J.M., Castle J., Bartel D.P., Linsley P.S., and Johnson J.M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433 (2005) 769-773
30. Liston P., Fong W.G., and Korneluk R.G. The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22 (2003) 8568-8580
31. Mendell J.T., Sharifi N.A., Meyers J.L., Martinez-Murillo F., and Dietz H.C. Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise. Nat. Genet. 36 (2004) 1073-1078
32. Moley J.F., Brother M.B., Fong C.T., White P.S., Baylin S.B., Nelkin B., Wells S.A., and Brodeur G.M. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes. Cancer Res. 52 (1992) 770-774
33. Mori N., Morosetti R., Spira S., Lee S., Ben-Yehuda D., Schiller G., Landolfi R., Mizoguchi H., and Koeffler H.P. Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. Blood 92 (1998) 3405-3409
34. Newton M.A., and Kendziorski C.M. Parametric empirical Bayes methods for microarrays. In: Parmigiani G., Garrett E.S., Irizarry R.A., and Zeger S.L. (Eds). The Analysis of Gene Expression Data: Methods and Software (2003), Springer Verlag, New York
35. Newton M.A., Kendziorski C.M., Richmond C.S., Blattner F.R., and Tsui K.W. On differential variability of expression ratios: improving statistical inference about gene expression changes from microarray data. J. Comput. Biol. 8 (2001) 37-52
36. O'Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., and Mendell J.T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435 (2005) 839-843
37. Ouyang H., Mou L., Luk C., Liu N., Karaskova J., Squire J., and Tsao M.S. Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am. J. Pathol. 157 (2000) 1623-1631
38. Poetsch M., Dittberner T., and Woenckhaus C. Microsatellite analysis at 1p36.3 in malignant melanoma of the skin: fine mapping in search of a possible tumour suppressor gene region. Melanoma Res. 13 (2003) 29-33
39. Rao P.K., Kumar R.M., Farkhondeh M., Baskerville S., and Lodish H.F. Myogenic factors that regulate expression of muscle-specific microRNAs. Proc. Natl. Acad. Sci. USA 103 (2006) 8721-8726
40. Rodriguez A., Griffiths-Jones S., Ashurst J.L., and Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 14 (2004) 1902-1910
41. Sheikh M.S., and Fornace Jr. A.J. Death and decoy receptors and p53-mediated apoptosis. Leukemia 14 (2000) 1509-1513
42. Thomson J.M., Parker J., Perou C.M., and Hammond S.M. A custom microarray platform for analysis of microRNA gene expression. Nat. Methods 1 (2004) 47-53
43. Vo N., Klein M.E., Varlamova O., Keller D.M., Yamamoto T., Goodman R.H., and Impey S. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc. Natl. Acad. Sci. USA 102 (2005) 16426-16431
44. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307-310
45. Voorhoeve P.M., le Sage C., Schrier M., Gillis A.J., Stoop H., Nagel R., Liu Y.P., van Duijse J., Drost J., Griekspoor A., et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124 (2006) 1169-1181
46. Waldman T., Kinzler K.W., and Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55 (1995) 5187-5190
47. Wei C.L., Wu Q., Vega V.B., Chiu K.P., Ng P., Zhang T., Shahab A., Yong H.C., Fu Y., Weng Z., et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 124 (2006) 207-219
48. Welch C., Chen Y., and Stallings R.L. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene (2007) 10.1038/sj.onc.1210293 in press. Published online February 12, 2007
49. Willis S., Day C.L., Hinds M.G., and Huang D.C. The Bcl-2-regulated apoptotic pathway. J. Cell Sci. 116 (2003) 4053-4056
50. Xi Y., Shalgi R., Fodstad O., Pilpel Y., and Ju J. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin. Cancer Res. 12 (2006) 2014-2024
51. Zhao Y., Samal E., and Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436 (2005) 214-220